» Articles » PMID: 36467072

Exercise-induced IL-15 Acted As a Positive Prognostic Implication and Tumor-suppressed Role in Pan-cancer

Overview
Journal Front Pharmacol
Date 2022 Dec 5
PMID 36467072
Authors
Affiliations
Soon will be listed here.
Abstract

Exercise can produce a large number of cytokines that may benefit cancer patients, including Interleukin 15 (IL-15). IL-15 is a cytokine that has multiple functions in regulating the adaptive and innate immune systems and tumorigenesis of lung and breast cancers. However, the roles of IL-15 in other types of cancer remain unknown. In this article, we try to systematically analyze if IL-15 is a potential molecular biomarker for predicting patient prognosis in pan-cancer and its connection with anti-cancer effects of exercise. The expression of IL-15 was detected by The Cancer Genome Atlas (TCGA) database, Human protein Atlas (HPA), and Genotype Tissue-Expression (GTEX) database. Analysis of IL-15 genomic alterations and protein expression in human organic tissues was analyzed by the cBioPortal database and HPA. The correlations between IL-15 expression and survival outcomes, clinical features, immune-associated cell infiltration, and ferroptosis/cuproptosis were analyzed using the TCGA, ESTIMATE algorithm, and TIMER databases. Gene Set Enrichment Analysis (GSEA) was performed to evaluate the biological functions of IL-15 in pan-cancer. The differential analysis suggested that the level of IL-15 mRNA expression was significantly downregulated in 12 tumor types compared with normal tissues, which is similar to the protein expression in most cancer types. The high expression of IL-15 could predict the positive survival outcome of patients with LUAD (lung adenocarcinoma), COAD (colon adenocarcinoma), COADREAD (colon and rectum adenocarcinoma), ESCA (esophageal carcinoma), SKCM (skin cutaneous melanoma), UCS (uterine carcinosarcoma), and READ (rectum adenocarcinoma). Moreover, amplification was found to be the most frequent mutation type of IL-15 genomic. Furthermore, the expression of IL-15 was correlated to the infiltration levels of various immune-associated cells in pan-cancer assessed by the ESTIMATE algorithm and TIMER database. In addition, IL-15 is positively correlated with ferroptosis/cuproptosis-related genes (ACSL4 and LIPT1) in pan-cancer. Levels of IL-15 were reported to be elevated in humans for 10-120 min following an acute exercise. Therefore, we hypothesized that the better prognosis of pan-cancer patients with regular exercise may be achieved by regulating level of IL-15. Our results demonstrated that IL-15 is a potential molecular biomarker for predicting patient prognosis, immunoreaction, and ferroptosis/cuproptosis in pan-cancer and partly explained the anti-cancer effects of exercise.

Citing Articles

Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer.

Dong S, Li A, Pan R, Hong J, Wang Z, Shen K Front Immunol. 2025; 16:1522149.

PMID: 39944694 PMC: 11813922. DOI: 10.3389/fimmu.2025.1522149.


Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion.

Huang P, Wang J, Yu Z, Lu J, Sun Z, Chen Z Front Immunol. 2025; 16:1537808.

PMID: 39911393 PMC: 11794230. DOI: 10.3389/fimmu.2025.1537808.


The role of cuproptosis in gastric cancer.

Li Y, Sun W, Yuan S, Liu X, Zhang Z, Gu R Front Immunol. 2024; 15:1435651.

PMID: 39539553 PMC: 11558255. DOI: 10.3389/fimmu.2024.1435651.


Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing.

Zhang S, Zhang X, Xiahou Z, Zuo S, Xue J, Zhang Y Front Immunol. 2024; 15:1470449.

PMID: 39430754 PMC: 11486721. DOI: 10.3389/fimmu.2024.1470449.


Exploring the relationship between the interleukin family and lung adenocarcinoma through Mendelian randomization and RNA sequencing analysis.

Zhi F, Liu W, Yang H, Luo H, Feng Y, Lei Y Discov Oncol. 2024; 15(1):436.

PMID: 39264458 PMC: 11393260. DOI: 10.1007/s12672-024-01325-1.


References
1.
Ochoa M, Minute L, Lopez A, Perez-Ruiz E, Gomar C, Vasquez M . Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15. Oncoimmunology. 2018; 7(2):e1393597. PMC: 5749662. DOI: 10.1080/2162402X.2017.1393597. View

2.
Zhang S, Zhao J, Bai X, Handley M, Shan F . Biological effects of IL-15 on immune cells and its potential for the treatment of cancer. Int Immunopharmacol. 2020; 91:107318. DOI: 10.1016/j.intimp.2020.107318. View

3.
Tamura Y, Watanabe K, Kantani T, Hayashi J, Ishida N, Kaneki M . Upregulation of circulating IL-15 by treadmill running in healthy individuals: is IL-15 an endocrine mediator of the beneficial effects of endurance exercise?. Endocr J. 2011; 58(3):211-5. DOI: 10.1507/endocrj.k10e-400. View

4.
Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4. PMC: 3956037. DOI: 10.1158/2159-8290.CD-12-0095. View

5.
Tang D, Chen X, Kroemer G . Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022; 32(5):417-418. PMC: 9061796. DOI: 10.1038/s41422-022-00653-7. View